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Introduction: Gout is characterized by episodes of intense joint inflammation in response to intra-articular
monosodium urate monohydrate (MSU) crystals. miR-155 is crucial for the proinflammatory activation of human
myeloid cells and antigen-driven inflammatory arthritis. The functional role of miR-155 in acute gouty arthritis has
not been defined. Therefore, the aim of this study was to examine the role of miR-155 in pathogenesis of acute
gouty arthritis.
Methods: Samples from 14 patients with acute gouty arthritis and 10 healthy controls (HCs) were obtained.
Peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) were cultured in vitro
with MSU crystals, and gene expression (human miR-155 and SHIP-1) were assessed by real-time PCR. THP-1 cells
were stimulated by MSU crystals and/or miR-155 transfection and then subjected to Western blot analysis. Levels of
human tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-1β in cell culture supernatants were measured by
Luminex. Immunohistochemistry was performed on formalin-fixed gout tissues with anti–SHIP-1 antibody.
A C57BL/6 J male mouse model of gout was used to analyze the expressions of miR-155, SHIP-1, and
inflammatory cytokines.
Results: The samples from gouty arthritis were highly enriched in miR-155, with levels of expression being higher
than those found in PBMC from HC. Treatment of the cells with MSU crystals strongly induced miR-155. In addition,
overexpression of miR-155 in the cells decreased levels of SHIP-1 and promoted production of MSU-induced
proinflammatory cytokines, such as TNF-α and IL-1β. Consistent with in vitro observations, miR-155 expression was
elevated in the mouse model of gout. The production of inflammatory cytokines was markedly increased in MSU
crystal induced peritonitis mice.
Conclusions: Overexpression of miR-155 in the gouty SFMC leads to suppress SHIP-1 levels and enhance
proinflammatory cytokines.Introduction
Gout is characterized by episodes of intense joint in-
flammation, in response tointra-articular monoso-
dium urate monohydrate (MSU) crystals [1]. This
inflammatory response is specifically initiated by
inflammasome activation within monocytes/macro-
phages, causing activation of inflammatory cytokines
within the joint [2].* Correspondence: ktj1562@jnu.ac.kr
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reproduction in any medium, provided the ormiRNA are noncoding RNA oligonucleotides that
have been highly conserved during evolution and
which have recently emerged as potent regulators of
gene expression of posttranscriptional regulators [3].
miRNA have been identified that appear to be crit-
ical for fine-tuning many biological processes, and
offers the prospect of multiple targets [4,5]. Emer-
ging data suggest that single miRNA species can
profoundly alter the phenotype and outcome of im-
mune responses [6-8].
miR-155 is crucial for the proinflammatory activation
of human myeloid cells and antigen-driven inflammatory
arthritis [9]. Peripheral blood mononuclear cells (PBMC)
in rheumatoid arthritis (RA) express elevated levels ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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activity [10]. Also, miR-155 is up-regulated in the syn-
ovial membrane of RA [11]. miR-155 has a dual effect
on the control of autoimmune-triggered destructive
arthritis. miR-155 deficiency inhibits the generation of
pathogenic self-reactive T and B cell responses. On the
other hand, miR-155 controls the development of local
bone destruction [12]. The functional role of miR-155 in
gouty arthritis has not been defined. Therefore, the aim
of this study was to examine the role of miR-155 in the
pathogenesis of acute gouty arthritis.
Methods
Sample collection
Samples from 14 patients with acute gouty arthritis and
10 healthy controls (HCs) were obtained. The clinical
features of the subjects are summarized in Table 1. The
paired samples of peripheral blood and synovial samples
were obtained from patients with joint effusion. The
presence of MSU crystals in all synovial fluid samples
was confirmed by polarizing light microscopy. It would
have been inappropriate to obtain synovial tissue sam-
ples from HCs for comparison with those obtained from
patients with gouty arthritis. Hence, we used synovial
tissue samples obtained from osteoarthritis (OA) pa-
tients, who underwent surgery of the knee joint and whoTable 1 Clinical and laboratory characteristics of patients




Total number 10 14
Age, mean (range) years* 51 (25 to 65) 55 (31 to 68)
Male, number (%)* 10 (100) 14 (100)
Duration of acute gout, mean (range) days NA 2 (1 to 4)
Co-morbidity NA
Diabetes, number (%) 3 (21.4)
Hypertension, number (%) 4 (28.5)
Hypercholesterolemia, number (%) 1 (7.1)
Cardiovascular disease, number (%) 2 (14.3)
Current medicines NA
Naive, number (%) 14 (100)
Location of arthritis NA
First MTP joint, number (%) 10 (71.4)
Knee joint, number (%) 12 (72.3)
Ankle joint, number (%) 2 (14.3)
Serum urate level, mean (range) mg/dl NA 7 (5 to 12)
ESR, mean (range, mm/h) NA 55 (45 to 61)
CRP, mean (range, mg/dL) NA 12.5 (5.8 to 18.3)
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MTP,
metatarsophalangeal; NA, not applicable. *Not significant.did not have a medical history of inflammatory arthritis,
as a representative sample of non-inflammatory syno-
vium based on a previous report [9]. The study was ap-
proved by the Institutional Review Board of Chonnam
National University Hospital, and written informed con-
sent was obtained from all participants.
MSU crystal synthesis
MSU crystals were prepared by recrystallization from
uric acid as previously described [13]. Briefly, 0.4 mg of
uric acid was dissolved in 80 ml of boiling distilled water
containing 2.45 ml of 1 N NaOH. After adjusting the pH
of the solution to 7.2 with HCl, the solution was grad-
ually cooled by stirring at room temperature and stored
overnight at 4°C. The crystals that formed were sterilized
by heating at 180°C for 2 h and suspended in PBS at a
concentration of 1 mg/ml. The crystals obtained by this
method were of comparable size (5 to 25 μm long) and
needle-shaped, negatively birefringent crystals observed
by compensated polarized light microscopy. Endotoxin
levels in MSU crystal preparations, as assessed by Limulus
amoebocyte cell lysate assay (Lonza, Walkersville, MD,
USA), were less than 0.01 IU/ml.
Isolation of PBMCs and synovial fluid mononuclear cells
(SFMCs), and MSU stimulation
Peripheral venous blood and synovial fluid samples
were collected in heparin-containing tubes. PBMCs and
SFMCs were isolated by density-gradient centrifugation
using Ficoll-Paque Plus solution (Amersham Biosci-
ences, Uppsala, Sweden). Freshly isolated PBMCs were
suspended in a complete medium, consisting of RPMI
1640, 2 mM L-glutamine, 100 units/ml of penicillin,
and 100 μg/ml of streptomycin, supplemented with 10%
FBS (Gibco BRL, Grand Island, NY, USA), and then
plated on 6-cm dishes at a density of 5 × 105 cells/ml.
After MSU crystals were added directly to the culture
plates, cells were cultured in completed media for the
indicated times (4, 12, 24, and 48 h) at 37°C in a 5%
CO2 humidified incubator for evaluation of miR-155
and Src homology 2-containing inositol phosphatase
(SHIP)-1 gene level.
Real-time polymerase chain reaction (PCR)
Total RNA was isolated using the miRNeasy kit (Qiagen,
Valencia, CA, USA). The miScript Reverse Transcription
Kit (Qiagen) was used for cDNA preparation. MiScript pri-
mer assay (Qiagen) was used for semiquantitative determin-
ation of the expression of human miR-155 (MS00003605).
The primer sequences were as follows: for human SHIP-1,
5′-GCC-TAC-ACC-AAG-CAG-AAA-GC-3′ (forward),
5′-GGA-CCG-TTC-TTG-GAG-ACA-AA-3′ (reverse). The
expression of U6B snRNA or β-actin was used as an en-
dogenous control. A threshold cycle (CT) was observed in
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tion of relative expression levels was performed using
standard curves for target genes and the endogenous
control. Geometric means were used to calculate the
ΔΔCT (delta-delta CT) values and are expressed as 2-
ΔΔCT. The value of each control sample was set at 1
and was used to calculate the fold-change of the target
genes.Cell culture and stimulation
Freshly isolated PBMCs were cultured in RPMI 1640 con-
taining 10% FBS with macrophage colony-stimulating fac-
tor (M-CSF; 30 ng/ml; PeproTech, London, UK). After
7 days, adherent cells were used as macrophages [14]. The
acute human monocytic leukaemia THP-1 cell line (TIB-
202; American Type Culture Collection, Manassas, VA,
USA) was used in a well-characterized model of acute
gout [2]. THP-1 cells were seeded on 6-cm dishes at a
density of 5 × 105 cells/ml: 50nM miR-155 (UUAAUG-
CUAAUCGUGAUAGGGGU) or 50 nM scramble control
(CCUACGCCACCAAUUUCGU) was mixed with Lipo-
fectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA)
in serum-free RPMI and transfected into the cells per
the manufacturer’s protocol. Optimal miR-155 expression
was confirmed at 24 h post-transfection by the qPCR ana-
lysis (See Additional file 1). After transfection, cells were
treated with phorbol 12-myristate 13-acetate/ionomycin
(PMA; 100 ng/ml) for 3 h to detect the levels of inflamma-
tory cytokines. This treatment increases the phagocytic
properties of the cells and induces a constitutive produc-
tion of proinflammatory cytokines [2]. After PMA stimu-
lation, cells were washed and then stimulated with MSU
(100 ug/ml) for 24 h, as described [15]. Human TNF-α
and IL-1β levels in cell culture supernatants were mea-
sured using Luminex (Millipore, Billerica, MA, USA) ac-
cording to the instructions of the manufacturer.Western blot analysis
Cells were harvested after washing with ice-cold PBS
and then lysed in extraction buffer (50 mM Tris/HCl
(pH 7.5), 150 mM NaCl, 2 mM EDTA, 1% Triton X-100,
1% sodium deoxycholate, 0.1% sodium dodecyl sulfate
(SDS) and 0.01% protease inhibitor cocktail). Whole-cell
lysates were subjected to 10% SDS- PAGE and western
blot analysis. Primary antibodies included anti-actin
(Sigma-Aldrich, St Louis, MO, USA), anti-SHIP-1, anti-
phospho-Akt, anti-Akt and anti-IκB-α (Cell Signaling
Technology, Beverly, MA, USA) antibodies, and horserad-
ish peroxidase (HRP)-conjugated secondary antibodies
(Amersham Biosciences, Pittsburgh, PA, USA) were used
and blots were developed with enhanced chemilumines-
cence (ECL) solution (Millipore Corporation, Billerica,
MA, USA). Signals were detected and analyzed using anLAS3000 luminescent image analyzer (Fuji Photo Film,
Tokyo, Japan) (See Additional file 2).
Immunohistochemical stain
The gout and osteoarthritis specimens were fixed in 4%
paraformaldehyde. The paraffin sections were immuno-
histochemically stained using LSAB2 system-HRP kit
(DakoCytomation, Carpinteria, CA, USA), according to
the manufacturer’s instruction. In brief, the sections
were deparaffinized, hydrated, and placed in peroxidase
block solution for 10 minute. After washing three times
in PBS, the sections were incubated with monoclonal
mouse SHIP-1 antibody (1:400, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) for 2 h, treated with biotinyl-
ated link solution for 20 minutes, and streptavidin-HRP
solution applied for 20 minutes. For the negative control,
primary antiserum was replaced with PBS. Consequently
the sections were treated with 3,3-diaminobenzidine
(DAB) substrate-chromogen solution for 10 minutes and
counterstained with Harris hematoxylin. Images were
photographed on a light microscope (Leica, Wetzlar,
Germany).
In vivo mouse peritonitis model
Male C57BL/6 J mice used for the experiments were aged
8 to 10 weeks. Peritonitis was induced by intra-peritoneal
injection of 3 mg MSU crystals in 250 μl PBS [16]. After
24 h, mice were killed by CO2 exposure and peritoneal
cavities were washed with 4 ml of PBS containing 25 units/
ml heparin. The cells were collected by peritoneal lavage
and analyzed for the expressions of miR-155 (MS00001701),
inflammatory cytokines by real-time PCR, and anti-
mouse SHIP-1 (Santa Cruz Biotechnology) antibody
was used for western blot. The sequences of the primers
used were as follows: for glyceraldehydes-3-phosphate
dehydrogenase (GAPDH), 5′-TGA-CCA-CAG-TCC-
ATG-CCA-TCA-CTG-3′ (forward), 5′-CAG-GAG-ACA-
ACC-TGG-TCC-TCA-GTG-3′ (reverse); for IL-1β,
5′- CTC-GTG-CTG-TCG-GAC-CCA-TAT-GAG-3′ (for-
ward), 5′-TGT-ACC-AGT-TGG-GGA-ACT-CTG-CAG-3′
(reverse); for TNF-α, 5′-GGC-TCC-AGG-CGG-TGC-
TTG-3′ (forward), 5′- GGG-CTA-CAG-GCT-TGT-CAC-
TCG −3′ (reverse).
Statistical analyses
The Mann–Whitney U-test was performed for continu-
ous variables that were not normally distributed, and
chi-square tests were used for categorical variables. The
Kruskal-Wallis test was used for the comparison of cyto-
kines among groups. Dunn’s test was used post-hoc to
compare all pairs of groups. A P-value <0.05 was con-
sidered statistically significant. All statistical analyses
were performed using SPSS version 17.0 software (SPSS,
Chicago, IL, USA).
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Increased expression levels of miR-155 in SFMCs of gouty
arthritis patients
We performed expression analysis of miR-155 in PBMCs
and SFMCs. The expression levels of miR-155 in SFMCs
from gout patients were significantly higher than those
in PBMC from HCs and patients (P <0.05) (Figure 1A).
Given our observation that miR-155 was over-expressed
in SFMCs of gout patients, we investigated whether
MSU, which is the key factor in gout pathogenesis, could
stimulate miR-155 expression. Freshly isolated PBMCs
from HCs were stimulated with MSU crystals for the in-
dicated times, and the expression level of miR-155 was
determined by real-time PCR. Expression of miR-155
was strongly induced by stimulation of MSU crystals
after 24 h (Figure 1B).
Decreased expression levels of SHIP-1 in SFMCs of gouty
arthritis patients
As SHIP-1 is a target of miR-155 [17-19], we focused on
the expression of SHIP-1 in gouty SFMCs. The expres-
sion of SHIP-1 mRNA was markedly down-regulated in
SFMCs of gouty arthritis patients compared with that in
PBMCs of gouty arthritis patients and normal controls
(Figure 2A). Moreover, the level of SHIP-1 mRNA was
gradually decreased in PBMCs of healthy donors that
were stimulated with MSU crystals (Figure 2B). We also
compared the expression of SHIP-1 in the synovial tissue
of gouty arthritis patients with that in the synovial tissue
of osteoarthritis patients. Immunohistochemical staining
revealed that the SHIP-1 protein was rarely expressed in
synovial lining cells of gouty arthritis patients as compared
to that in synovial lining cells of OA patients (Figure 2C).
THP-1 cells were stimulated or not, with miR-155 and/or
MSU crystal, as described in the Methods section. A rep-
resentative immunoblot showed that the SHIP-1 proteinFigure 1 miR-155 is overexpressed in synovial fluid mononuclear cell
stimulation with monosodium urate (MSU) crystals. (A) Samples from 1
synovial fluid from 14 patients with acute gouty arthritis were obtained. (B
HCs were cultured for the indicated times in the presence of MSU crystals
PCR analysis was performed to determine the expressions of miR-155. Resu
shown as the mean ± standard error of the mean (SEM). *p <0.05, Mann–Wlevel was partially decreased in the presence of miR-155
and/or MSU crystal stimulation; and more so, when the
two conditions were simultaneously met. The phosphoryl-
ation of Akt was enhanced, when the levels of SHIP-1 were
lowered. The level of NFκB inhibitor (IκB) was decreased
under the same conditions, a probable consequence of the
increased phosphorylation of Akt (Figure 2D). Given the
interaction of miR-155 and SHIP-1, these data indicate
that the SHIP-1 expression was suppressed in acute gouty
arthritis due to the over expression of miR-155 and stimu-
lation with MSU crystals.MiR-155 promotes the production of pro-inflammatory
cytokines
Cytokine levels in cell culture supernatants were mea-
sured. Cells that encounter MSU crystals express a
broad array of inflammatory mediators that contribute
to acute gouty inflammation [20]. TNF-α level (mean ±
standard error of the mean (SEM)) was significantly
higher in the miR-155-transfected or in MSU crystal-
stimulated samples than in controls (73.95 ± 5.65 versus
6.86 ± 0.09, and 107.11 ± 5.77 versus 6.86 ± 0.09, respect-
ively). Furthermore, the TNF-α level was dramatically in-
creased by both miR-155 transfection and MSU crystal
stimulation (131.95 ± 6.14) (Figure 3A). The IL-1β level
was not significantly higher in miR-155-only transfected
supernatants than in controls (2.65 ± 0.59 versus 0.28 ±
0.03). However, the IL-1β level was increased by stimula-
tion with MSU crystals only (59.42 ± 6.59). Even though
miR-155 did not enhance the production of IL-1β, miR-
155 promoted IL-1β levels adding to MSU crystal (88.45 ±
2.56) (Figure 3B). Thus, overexpression of miR-155
triggered the production of proinflammatory cytokines,
which are strongly implicated in the pathogenesis of
gouty arthritis.s (SFMCs) from patients with gouty arthritis and up-regulated by
0 healthy controls (HCs), and paired ones of peripheral blood and
) Freshly isolated peripheral blood mononuclear cells (PBMCs) from
(100 μg/ml). Total RNA was collected from each time point. Real-time
lts are representative of nine independent experiments. Values are
hitney U-test.
Figure 2 Decreased expression of Src homology 2-containing inositol phosphatase-1 (SHIP-1) in gouty arthritis. (A) Expression of mRNA
for SHIP-1 in peripheral blood mononuclear cells (PBMCs) from healthy controls (HCs), PBMCs and synovial fluid mononuclear cells (SFMCs) of
gouty arthritis patients. (B) PBMCs from HCs were cultured for the indicated times in the presence of the monosodium urate (MSU) crystals.
Real-time PCR was performed to determine the mRNA expression of SHIP-1. Results are representative of three independent experiments. Values
are shown as the mean ± standard error of the mean. (C) Synovial specimens from acute gouty arthritis and osteoarthritis patients were processed
for immunohistochemical staining using anti-human SHIP-1 antibody. Scale bars in d = 50 μm. (D) THP-1 cells were stimulated or not, with MSU
crystal and/or miR-155 tranfection. The scrambled controls were transfected in all of miR-155 negative cells to rule out the possibility of a
non-specific anti-RNA response. It was analyzed by western blot for SHIP-1, phophrylated Akt, total Akt, IkB proteins. *P <0.05, Mann–Whitney
U-test. OA, osteoarthritis.
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of gout
We next examined the contribution of miR-155 to the
development of disease in the gout mouse model. Con-
sistent with our in vitro observations, cells isolated fromFigure 3 miR-155 promotes the production of inflammatory cytokine
scrambled control were mixed with Lipofectamine 2000 Reagent in serum-
transfection, cells were treated with phorbol 12-myristate 13-acetate/ionom
washed and then stimulated with MSU (100 ug/ml) for 24 h. Human TNF-α
using Luminex. *P <0.05, post-hoc analysis after the Kruskal-Wallis test.mice with MSU crystal-induced peritonitis showed
significantly increased mRNA levels of TNF-α and
IL-1β (Figure 4A). miR-155 expression was elevated
in the mouse model of gout, compared to controls
(Figure 4B). In addition, SHIP-1 protein levels weres over monosodium urate (MSU) crystal stimulation. miR-155 or
free RPMI and transfected into the THP-1 cells. After 24 h of
ycin (PMA) (100 ng/ml) for 3 h. After stimulation with PMA, cells were
(A) and IL-1β (B) levels in cell culture supernatants were measured
Figure 4 Involvement of miR-155 as ascertained in the mouse gout peritonitis model. Male C57BL/6 J mice (n = 3 per group) used for the
experiments were aged 8 to 10 weeks. Peritonitis was induced by intraperitoneal injection of 3 mg monosodium urate crystals in 250 μl PBS.
After 24 h, mice were killed and 4 ml PBS containing 25 units/ml heparin was injected into each peritoneal cavity. The peritoneal lavage fluid was
aspirated and infiltrated cells were harvested. (A) Inflammatory cytokines were up-regulated. Real-time PCR was performed to determine the
mRNA expression of TNF-α and IL-1β. (B) miR-155 is up-regulated in the gout mouse model. (C) Src homology 2-containing inositol
phosphatase-1 (SHIP-1) protein level was suppressed on western blot analysis. Values are shown as the mean ± standard error of the mean.
*P <0.05, Mann–Whitney U-test.
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lavage (Figure 4C).
Discussion
Emerging data suggest that single miRNA species can
profoundly alter the phenotype and outcome of immune
responses. Dysregulation of miRNA levels has been re-
ported in a number of pathologic conditions [3]. More
than 100 miRNAs are expressed by cells of the immune
system, and they have the potential to broadly influence
the molecular pathways that control the development
and function of immune responses [4]. Of those, miR-
155 has been implicated in the differentiation and activa-
tion of cells of both the adaptive and the innate immune
systems [4]. Expression of miR-155 has been demon-
strated in the context of several autoimmune diseases,
including RA. Up-regulated expression of miR-155 in
PBMC and synovial membrane cells of RA patients has
been observed [10,11]. miR-155 can be induced in mac-
rophages in response to both bacterial and viral-derived
antigens that activate Toll-like receptors (TLRs) [21,22].
Gout is an autoinflammatory disorder associated with
deposition of MSU crystals in joints and peri-articular
tissues. Reported advances suggest that the innate im-
mune system drives the gouty inflammatory response toMSU [23]. However, given the redundant and highly
cell-specific effects mediated by miRNAs species, the
precise functional implications of miR-155 expression
in the pathogenesis of gouty arthritis have remained
obscure.
In this study, miR-155 was up-regulated in SFMCs
from patients with gouty arthritis. Furthermore, our
in vitro experiments showed that MSU crystals induced
increased levels of miR-155. miRNA controls gene ex-
pression by targeting mRNA and triggering either trans-
lation repression or RNA degradation [3]. Therefore, the
prospect of targeting multiple pathways simultaneously
is attractive to optimize the neutralization of complex ef-
fector immune pathways. Given the evidence for direct
interaction between miR-155 and SHIP-1 [17-19], we ex-
plored SHIP-1 in the present study. This molecule also
has been reported to be a target of miR-155 in the hu-
man RA monocyte [9]. In our data, lower expressions of
SHIP-1 from gouty SFMC were observed, comparing to
those from HC. In vitro, SHIP-1 level was gradually de-
creased by MSU crystal-mediated stimulation. Interest-
ingly, our histological observation also revealed that the
expressions of SHIP-1 in acute gout samples were fewer
than those in OA samples. In addition, SHIP-1 proteins
were markedly reduced according to enhancing miR-155
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expression of miR-155 contribute to down-regulation of
SHIP-1 in gouty SFMC.
Cells that encounter MSU crystals express a broad array
of inflammatory mediators that contribute to acute gouty
inflammation [15]. The role of SHIP-1 is essential for the
suppressor activity of macrophages and is a potent inhibi-
tor of many inflammatory pathways [24,25]. Recently, it
has been shown that monocytes and macrophages overex-
pressing miR-155 exhibit decreased SHIP-1 expression that
may lead to increased production of pro-inflammatory cy-
tokines [9]. It can be assumed that the miR-155/SHIP
pathway might be responsible for causing excessive pro-
inflammatory activation in gouty arthritis. In our cellu-
lar biochemical results, a trend (P-value not significant)
towards increasing levels of phosphatidylinositol tri-
phosphate (PtdIns-3,4,5-P3) was observed after miR-155
transfection and MSU crystal stimulation (see Additional
file 3). Although it appeared that MSU crystal increased
PtdIns-3,4,5-P3 levels, this effect was not significantly
amplified in the presence of miR-155. The rapid rise and
transient accumulation are the main characteristics of
PtdIns-3,4,5-P3. Therefore, the possible reason was due to
the difficulties of the measurements. Even though the ac-
curacy and sensitivity of the assay for phosphoinositides
have been improved, tissue extracts contain large quan-
tities of lipids other than the phosphoinositides, which
might be expected to interfere nonspecifically. Among the
downstream molecules of PtdIns-3,4,5-P3, Akt is known
to phosphorylate IκB kinase (IKK) thereby promoting acti-
vation of NF-kB, which is a key factor for inflammatory
cytokines [26]. Therefore, in our study, miR-155 decreased
the SHIP-1 level, the levels of phosphorylation of Akt were
increased, and as a probable consequence, the NF-kB
pathway was activated.
With respect to inflammatory cytokines, our in vitro
experiments demonstrate that MSU crystals trigger the
production of TNF-α in supernatants from stimulated
monocytes. Furthermore, miR-155 promoted MSU crystal-
induced TNF-α production. Although we could not con-
firm the increased level of IL-1β induced by miR-155
alone, miR-155 aided IL-1β production in supernatants
from MSU crystal-stimulated monocytes. In particular, the
elevated levels of pro-inflammatory cytokines, such as IL-
1β and TNF-α, in the synovial fluid of patients with gout
[27,28], may be associated with miR-155-mediated regula-
tion of monocyte/macrophage responses to MSU crystals.
Taken together, these findings indicate that the pro-
inflammatory phenotype in acute gouty arthritis could be
regulated by aberrant expression of miR-155. Our in vivo
data demonstrated that increased miR-155 expression fol-
lowing stimulation with MSU stimulation plays a role in
down-regulation of SHIP-1 protein. Consistent with a cru-
cial role of miR-155 in the regulation of pro-inflammatorycytokine production in vitro, investigations from gout mice
model showed that the pro-inflammatory cytokine levels
were enhanced in accordance with decreasing levels of
SHIP-1.
We have to consider whether miR-155 enhanced proin-
flammatory cytokines via other pathways, in addition to
SHIP-1 signaling on monocytes. It was demonstrated that
Akt was directly activated through miR-155–mediated
suppression of the phosphatase protein phosphatase 2A
catalytic subunit alpha [29]. Jiang et al. demonstrated that
miR-155 expression was inversely correlated with the Sup-
pressor of cytokine signaling 1 (SOCS1) gene, that normally
functions as a negative feedback regulator of Janus-
activated kinase (JAK)/signal transducer, and activator of
transcription (STAT) signaling [30]. A recent report also
revealed that miR-155 may contribute to experimental
autoimmune encephalomyelitis, by promoting the devel-
opment of inflammatory T cells [31]. Further research on
both direct and indirect effects of miR-155 on inflamma-
tion by the MSU crystal stimulation are required.
In summary, this study is the first research to examine
the role of mirRNA in acute gouty arthritis. miR-155
was up-regulated in SFMCs of patients with gouty arth-
ritis. The pro-inflammatory phenotype in acute gouty
arthritis could be regulated by aberrant expression of
miR-155. These data provide a strong proof-of-concept
for miR-155-based therapeutic approaches that could
modulate inflammation in acute gout.
Conclusion
The miR-155 was up-regulated in SFMCs from patients with
acute gouty arthritis. The increased expression of miR-155
in SFMCs was associated with lower expression of SHIP-1,
an inhibitor of inflammation. Overexpression of miR-155 in
SFMC led to down-regulation of SHIP-1. Then Akt/NF-kB
pathway was activated, and as a consequence, the produc-
tion of pro-inflammatory cytokines was enhanced.
Additional files
Additional file 1: Efficient transfection of cells with miR-155. THP-1
cells were transfected with miR-155 or control. After 24 h, cells were
analyzed by real-time PCR for miR-155 expression. Data are shown as the
means ± standard error of the mean of three experiments.
Additional file 2: Original blot data.
Additional file 3: Phosphatidylinositol triphosphate (PtdIns-3,4,
5-P3) level with miR-155 and/or monosodium urate (MSU) crystal
stimulation. THP-1 cells were transfected with miR-155 or scamble
control. After transfection, cells were treated with or without MSU crystal.
Cells were analyzed according to phosphoinositide mass assays (Analytical
Biochemistry 313 (2003) 234–245). Data are shown as the means ± standard
error of the mean of three experiments.
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